Entitlement offer at 8c closes today

A reminder to fellow shareholders of our Wise Owl cannabis Investment, Bod Australia (ASX:BOD), that today is the final day to take up its 4-for-17 pro rata, non-renounceable entitlement offer at 8c per share, in which we are participating.

BOD is acquiring a cannabis product and process technology that allows more rapid onset, better efficacy and lower dosage rates of cannabidiol (CBD) products – resulting in raw material cost savings and fewer patient side effects.

Following the capital raise, BOD is expected to have over $5M in cash, and a market cap of $12M.

Whilst its been a rough ride for BOD holders lately, we think this could be the bottom for the share price. We are hoping this acquisition gives the company fresh momentum, which is timed with a resurgence in the sentiment of cannabis stocks that we predict will occur in 2023.

For a full update on BOD, its new cannabis acquisition, and how BOD can build value from here, check out our latest commentary: BOD’s big bet – will it pay off?